Sort
326,823 grants matching “clinical trial”
Mitochondrial Complex I as a Target for Neuroprotection in AD
$2,271,860Eugenia Trushina · Mayo Clinic Rochester · RF1 · FY2022 · AG
Cancer Center Support Grant
$2,271,814Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2021 · CA
Developmental and HyperActive Ras Tumor SPORE
$2,271,783David W. Clapp · Indiana University Indianapolis · U54 · FY2017 · CA
DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*
$2,271,783Samson T Jacob · Ohio State University · P01 · FY2008 · CA
Development of inhibitors of AMP Deaminase Isoform 2 as a Mechanism for Treating
$2,271,441Richard Joseph Johnson · University Of Colorado Denver · RC4 · FY2010 · DK
Immunotherapy of low grade lymphoid malignancies
$2,271,399Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Entorhinal-hippocampal interactions during progressive memory impairments in mouse models of Alzheimer's disease pathology
$2,271,330Tristan Shuman · Icahn School Of Medicine At Mount Sinai · RF1 · FY2022 · AG
Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma
$2,271,313Angela Nicole Koehler · Massachusetts Institute Of Technology · UM1 · FY2025 · CA
Early Biomarkers of Autism Spectrum Disorders in infants with Tuberous Sclerosis
$2,271,003Mustafa None Sahin · Boston Children'S Hospital · U01 · FY2016 · NS
Anti-NMDA receptor antibodies in adult brain dsyfunction & fetal brain developmen
$2,270,547Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2017 · AI
Anti-NMDA receptor antibodies in adult brain dsyfunction & fetal brain developmen
$2,270,547Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2015 · AI
Anti-NMDA receptor antibodies in adult brain dsyfunction & fetal brain developmen
$2,270,547Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2016 · AI
Mitochondria and metabolism in neurodegeneration
$2,270,540John William Elrod · Temple Univ Of The Commonwealth · RF1 · FY2021 · NS
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
$2,270,520Cassian Yee · University Of Tx Md Anderson Can Ctr · UH3 · FY2025 · CA
Regulatory Support for Cancer Prevention Agent Development
$2,270,504Caroline C Sigman · Ccs Associates, Inc. · N02 · FY2016 · CA
Lung Transplant Consortium - Data Coordinating Center
$2,270,471Scott M Palmer · Duke University · U24 · FY2025 · HL
Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN PATHS) study
$2,270,391Emily Ai-Hua Wang · Yale University · UG1 · FY2020 · DA
HIV Subtype C Alphavirus Vaccine Design &Development
$2,270,241Alphavax Human Vaccines, Inc. · U01 · FY2002 · AI
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,270,149Dartmouth College · P20 · FY2002 · RR
Upper Gastrointestinal Cancer Studies
$2,270,068Christian Abnet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
BCM CLINICAL SITE FOR AN UNDIAGNOSED DISEASES NETWORK (UDN)
$2,270,067Brendan Hl Lee · Baylor College Of Medicine · U01 · FY2016 · HG
Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials
$2,270,000Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2023 · AG
Clinic, Family & Community Collaboration to Treat Overweight and Obese Children
$2,269,982Thomas N Robinson · Stanford University · U01 · FY2015 · HL
Anatomic Pathology Residency Program
$2,269,964Frederic Barr · Division Of Basic Sciences - Nci · ZIE · FY2021 · CA
THE IMMUNOLOGY DATABASE AND ANALYSIS PORTAL (IMMPORT)
$2,269,736Atul Butte · · N01 · FY2025 · AI